SLC30A8 SNPs | Control | GADA negative diabetes | Recessive | Dominant | Additive | ||
---|---|---|---|---|---|---|---|
OR (95% CI) | |||||||
Freq. | 11/12/22 | Freq. | 11/12/22 | P-value | |||
rs7002176 (A  > T ) | |||||||
Combined* | 0.42 | 113/284/208 | 0.45 | 222/541/335 | 1.12(0.85–1.46) 0.43 | 1.17(0.93–1.47) 0.18 | 1.11(0.95–1.29) 0.19 |
Malay# | 0.37 | 35/115/100 | 0.42 | 79/191/150 | 1.61(1.00–2.59) 0.05 | 1.16(0.80–1.67) 0.43 | 1.23(0.96–1.57) 0.11 |
Chinese# | 0.48 | 46/98/55 | 0.47 | 56/160/75 | 0.70(0.43–1.14) 0.15 | 1.06(0.67–1.65) 0.81 | 0.89(0.67–1.19) 0.43 |
Indian# | 0.43 | 32/71/53 | 0.47 | 87/190/110 | 1.12(0.70–1.78) 0.65 | 1.32(0.88–1.99) 0.18 | 1.22(0.93–1.60) 0.15 |
rs1995222 ( A  < G) | |||||||
Combined* | 0.63 | 238/273/87 | 0.67 | 498/440/138 | 1.29(1.03–1.62) 0.02 | 1.17(0.85–1.60) 0.34 | 1.18(1.01–1.39) 0.039 |
Malay# | 0.60 | 88/116/40 | 0.64 | 167/189/54 | 1.22(0.85–1.77) 0.28 | 1.55(0.93–2.58) 0.10 | 1.24(0.95–1.61) 0.11 |
Chinese# | 0.54 | 57/97/43 | 0.54 | 87/133/66 | 1.16(0.75–1.79) 0.51 | 0.97(0.60–1.56) 0.89 | 1.05(0.80–1.38) 0.73 |
Indian# | 0.78 | 93/60/4 | 0.80 | 244/118/18 | 1.26(0.85–1.87) 0.25 | 0.27(0.06–1.22) 0.09 | 1.11(0.79–1.56) 0.53 |
rs13266634 (C  > T ) | |||||||
Combined* | 0.60 | 223/284/105 | 0.65 | 506/415/181 | 1.45(1.16–1.81) 0.001 | 0.99(0.75–1.32) 0.96 | 1.18(1.01–1.37) 0.03 |
Malay# | 0.58 | 84/127/42 | 0.60 | 158/192/73 | 1.16(0.80–1.66) 0.44 | 0.85(0.53–1.35) 0.49 | 1.02(0.79–1.30) 0.90 |
Chinese# | 0.50 | 56/90/56 | 0.49 | 85/115/91 | 1.14(0.74–1.76) 0.55 | 0.93(0.61–1.44) 0.76 | 1.03(0.79–1.33) 0.84 |
Indian# | 0.74 | 83/67/7 | 0.82 | 263/108/17 | 1.93(1.31–2.85) 0.001 | 0.81(0.31–2.14) 0.68 | 1.58(1.14–2.17) 0.006 |